Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women
Author(s) -
Mark J. Abzug,
Sharon Nachman,
Petronella Muresan,
Edward Handelsman,
D. Heather Watts,
Terence Fenton,
Barbara Heckman,
Elizabeth Petzold,
Adriana Weinberg,
Myron J. Levin,
George K. Siberry,
Judi Miller,
Wende Levy,
Ruth Ebiasah,
Paul Palumbo,
Joan Dragavon,
Lori Donelson,
Andrea Jurgrau,
David Garry,
A. Anthony Bloom
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit057
Subject(s) - immunogenicity , medicine , pandemic , vaccination , virology , human immunodeficiency virus (hiv) , pregnancy , immunology , covid-19 , antibody , biology , disease , infectious disease (medical specialty) , genetics
Pregnant women infected with human immunodeficiency virus (HIV) may have particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and immunogenicity of pH1N1 vaccination in HIV-infected pregnant women are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom